Analytical validation of a novel multi-analyte plasma test for lung nodule characterization

BACKGROUND: In the National Lung Screening Trial, 96.4% of nodules had benign etiology. To avoid unnecessary actions and exposure to harm, individuals with benign disease must be identified. We describe herein the analytical validation of a multi-analyte immunoassay for characterizing the risk that...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Neil N, Brown, James K, Rubenstein, Tess, Rostykus, Abigail D, Fish, Amanda L, Yu, Heng, Carbonell, Luis, Juang, Alice, Kamer, Sandy, Patel, Bhavin, Sidhu, Manpreet, Vuong, Doris, Wang, Shan, Beggs, Mike, Wu, Alan HB, Arjomandi, Mehrdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486005/
https://www.ncbi.nlm.nih.gov/pubmed/32923944
http://dx.doi.org/10.15761/brr.1000123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7486005/
https://www.ncbi.nlm.nih.gov/pubmed/32923944
http://dx.doi.org/10.15761/brr.1000123

Ejemplares similares